SCHEMBL17876101

SCHEMBL17876101

c1ccc2c(c1)oc1ccc(-c3ccc4c(c3)-c3cc(-c5cccc6oc7ccccc7c56)ccc3OCO4)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.42
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 6/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
HPGD P15428 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
TNKS O95271 1/20 0.42
PDE10A Q9Y233 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
HTT P42858 3/20 0.40
TP53 P04637 1/20 0.40
ALOX12 P18054 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
PTPRC P08575 1/20 0.40
ALOX5 P09917 1/20 0.39
AHR P35869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876048 0.95 PTPRC (0.42) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876049 0.95 PTPRC (0.42) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876106 0.93 NPC1 (0.47) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876097 0.92 ALDH1A1 (0.42) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876100 0.91 MAPT (0.49) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876091 0.89 ALOX5 (0.53) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876089 0.89 ALOX5 (0.53) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876108 0.89 L3MBTL1 (0.42) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876053 0.88 NPC1 (0.46) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL17876032 0.88 PTPRC (0.42) MAPTKDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885ALDH1A1 1061/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885ALDH1A1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.